| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Yu-Chieh Chen | |
| Li-Tung Huang | |||
| Jiunn-Ming Sheen | |||
| Mei-Hsin Hsu | |||
| P2860 | cites work | The Good, the Bad, and the Ugly of Pregnancy Nutrients and Developmental Programming of Adult Disease | Q90191063 |
| Maternal insulin resistance multigenerationally impairs synaptic plasticity and memory via gametic mechanisms | Q90883982 | ||
| Health benefits of resveratrol: Evidence from clinical studies | Q91448150 | ||
| Systematic review: Impact of resveratrol exposure during pregnancy on maternal and fetal outcomes in animal models of human pregnancy complications-Are we ready for the clinic? | Q91567862 | ||
| Maternal pre-pregnancy obesity, offspring cord blood DNA methylation, and offspring cardiometabolic health in early childhood: an epigenome-wide association study | Q91660769 | ||
| Resveratrol prevents combined prenatal NG-nitro-L-arginine-methyl ester (L-NAME) treatment plus postnatal high-fat diet induced programmed hypertension in adult rat offspring: interplay between nutrient-sensing signals, oxidative stress and gut micr | Q92159852 | ||
| The association between maternal body mass index and child obesity: A systematic review and meta-analysis | Q92657034 | ||
| Effect of resveratrol on adipokines and myokines involved in fat browning: Perspectives in healthy weight against obesity | Q92870747 | ||
| Intrauterine programming of obesity and type 2 diabetes | Q92883982 | ||
| Prevalence and Trends in Obesity Among US Adults, 1999-2000 | Q22253005 | ||
| Maternal obesity during pregnancy and cardiovascular development and disease in the offspring | Q26786041 | ||
| Inflammation in maternal obesity and gestational diabetes mellitus | Q26829979 | ||
| Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha | Q28274682 | ||
| Socioeconomic position across life and body composition in early old age: findings from a British birth cohort study | Q28659302 | ||
| Interventions to prevent maternal obesity before conception, during pregnancy, and post partum. | Q30061926 | ||
| Nurturing care: promoting early childhood development. | Q30061932 | ||
| Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans | Q32774312 | ||
| Maternal diet-induced obesity alters mitochondrial activity and redox status in mouse oocytes and zygotes | Q33559715 | ||
| Fetal programming of adipose tissue: effects of intrauterine growth restriction and maternal obesity/high-fat diet | Q33567132 | ||
| Resveratrol suppresses body mass gain in a seasonal non-human primate model of obesity | Q33613030 | ||
| Beneficial and cautionary outcomes of resveratrol supplementation in pregnant nonhuman primates | Q33613239 | ||
| Consumption of a Western-style diet during pregnancy impairs offspring islet vascularization in a Japanese macaque model | Q33839916 | ||
| Oxidative stress and altered lipid homeostasis in the programming of offspring fatty liver by maternal obesity | Q33840339 | ||
| Biological effects of resveratrol | Q33841550 | ||
| Overnutrition and maternal obesity in sheep pregnancy alter the JNK-IRS-1 signaling cascades and cardiac function in the fetal heart | Q33868714 | ||
| Maternal overweight programs insulin and adiponectin signaling in the offspring. | Q33874488 | ||
| Increasing maternal body mass index is associated with systemic inflammation in the mother and the activation of distinct placental inflammatory pathways. | Q33888360 | ||
| Obesity and pregnancy: complications and cost | Q33911797 | ||
| Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent | Q34580037 | ||
| Pre-pregnancy body mass index in relation to infant birth weight and offspring overweight/obesity: a systematic review and meta-analysis | Q34684703 | ||
| Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta | Q34824188 | ||
| Of the bugs that shape us: maternal obesity, the gut microbiome, and long-term disease risk | Q35331208 | ||
| Adverse fetal and neonatal outcomes associated with a life-long high fat diet: role of altered development of the placental vasculature | Q35839882 | ||
| Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet | Q35976627 | ||
| The cellularity of offspring's adipose tissue is programmed by maternal nutritional manipulations | Q35998814 | ||
| Host remodeling of the gut microbiome and metabolic changes during pregnancy | Q36421887 | ||
| Chorionic plate arterial function is altered in maternal obesity. | Q36708383 | ||
| Programmed hyperphagia in offspring of obese dams: Altered expression of hypothalamic nutrient sensors, neurogenic factors and epigenetic modulators | Q36743919 | ||
| Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia | Q36875755 | ||
| Maternal Obesity Promotes Diabetic Nephropathy in Rodent Offspring | Q36986185 | ||
| MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity | Q37163542 | ||
| Maternal obesity enhances white adipose tissue differentiation and alters genome-scale DNA methylation in male rat offspring. | Q37240132 | ||
| Maternal obesity during pregnancy and premature mortality from cardiovascular event in adult offspring: follow-up of 1 323 275 person years | Q37248206 | ||
| Maternal obesity induced by a high fat diet causes altered cellular development in fetal brains suggestive of a predisposition of offspring to neurological disorders in later life | Q37308482 | ||
| Early-life origins of metabolic dysfunction: role of the adipocyte | Q37354515 | ||
| Maternal high-fat diet and fetal programming: increased proliferation of hypothalamic peptide-producing neurons that increase risk for overeating and obesity | Q37362994 | ||
| Maternal exposure to a Western-style diet causes differences in intestinal microbiota composition and gene expression of suckling mouse pups. | Q37561022 | ||
| Developmental Programming of Adult Disease: Reprogramming by Melatonin? | Q37691012 | ||
| Maternal obesity and diabetes may cause DNA methylation alteration in the spermatozoa of offspring in mice | Q37699589 | ||
| Obesity, pregnancy, inflammation, and vascular function. | Q37705670 | ||
| Developmental origins of obesity-related hypertension | Q37908163 | ||
| The role of nutrition on epigenetic modifications and their implications on health. | Q38024590 | ||
| Maternal obesity, lipotoxicity and cardiovascular diseases in offspring. | Q38043806 | ||
| Developmental ORIgins of Healthy and Unhealthy AgeiNg: the role of maternal obesity--introduction to DORIAN. | Q38209730 | ||
| Maternal obesity alters brain derived neurotrophic factor (BDNF) signaling in the placenta in a sexually dimorphic manner | Q38289614 | ||
| Maternal obesity up-regulates inflammatory signaling pathways and enhances cytokine expression in the mid-gestation sheep placenta. | Q38346228 | ||
| Risks associated with obesity in pregnancy, for the mother and baby: a systematic review of reviews. | Q38504330 | ||
| Obesity and Placental Function. | Q38687952 | ||
| Resveratrol and the mitochondria: From triggering the intrinsic apoptotic pathway to inducing mitochondrial biogenesis, a mechanistic view | Q38708678 | ||
| Maternal obesity and neurodevelopmental and psychiatric disorders in offspring. | Q38967795 | ||
| AMPK activation prevents prenatal stress-induced cognitive impairment: modulation of mitochondrial content and oxidative stress | Q38968787 | ||
| Placental Lipid and Fatty Acid Transfer in Maternal Overnutrition. | Q39182302 | ||
| Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): a multicentre, randomised controlled trial | Q41594101 | ||
| Efficacy of resveratrol to supplement oral nifedipine treatment in pregnancy-induced preeclampsia | Q42269581 | ||
| Maternal and postweaning high-fat diets disturb hippocampal gene expression, learning, and memory function | Q42642997 | ||
| Resveratrol improves postnatal hippocampal neurogenesis and brain derived neurotrophic factor in prenatally stressed rats. | Q42710266 | ||
| Maternal intake of quercetin during gestation alters ex vivo benzo[a]pyrene metabolism and DNA adduct formation in adult offspring | Q42721278 | ||
| Steady-State pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects. | Q43042961 | ||
| Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women | Q43141586 | ||
| Maternal high-fat diets cause insulin resistance through inflammatory changes in fetal adipose tissue. | Q44027660 | ||
| SIRT1-dependent modulation of methylation and acetylation of histone H3 on lysine 9 (H3K9) in the zygotic pronuclei improves porcine embryo development | Q44572962 | ||
| Safety studies conducted on high-purity trans-resveratrol in experimental animals. | Q45978118 | ||
| Diet-induced obesity in female mice leads to peroxidized lipid accumulations and impairment of hippocampal neurogenesis during the early life of their offspring | Q46154208 | ||
| Role of resveratrol in regulation of cellular defense systems against oxidative stress. | Q46250411 | ||
| Placental structure and inflammation in pregnancies associated with obesity. | Q46328759 | ||
| Developmental programming of aortic and renal structure in offspring of rats fed fat-rich diets in pregnancy | Q46387175 | ||
| Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats | Q46542331 | ||
| Diet-induced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance: a novel murine model of developmental programming | Q46845260 | ||
| Maternal interleukin-6: marker of fetal growth and adiposity | Q46869079 | ||
| Resveratrol Role in Autoimmune Disease-A Mini-Review. | Q47158536 | ||
| Associations of gestational weight gain with offspring body mass index and blood pressure at 21 years of age: evidence from a birth cohort study | Q47191022 | ||
| Developmental origins of adult health and disease: The metabolic role of BDNF from early life to adulthood | Q47348453 | ||
| Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. | Q47414505 | ||
| Resveratrol Intake During Pregnancy and Lactation Modulates the Early Metabolic Effects of Maternal Nutrition Differently in Male and Female Offspring | Q47571626 | ||
| Can trans resveratrol plus d-chiro-inositol and myo-inositol improve maternal metabolic profile in overweight pregnant patients? | Q47768063 | ||
| Resveratrol reverses the effects of chronic unpredictable mild stress on behavior, serum corticosterone levels and BDNF expression in rats | Q47802005 | ||
| Resveratrol supplementation of high-fat diet-fed pregnant mice promotes brown and beige adipocyte development and prevents obesity in male offspring. | Q47933608 | ||
| Maternal obesity impairs hippocampal BDNF production and spatial learning performance in young mouse offspring | Q48170499 | ||
| Established maternal obesity in the rat reprograms hypothalamic appetite regulators and leptin signaling at birth | Q48849303 | ||
| Maternal resveratrol consumption and its programming effects on metabolic health in offspring: mechanisms and potential implications | Q50043500 | ||
| Health Effects of Overweight and Obesity in 195 Countries | Q50094600 | ||
| Perinatal Resveratrol Supplementation to Spontaneously Hypertensive Rat Dams Mitigates the Development of Hypertension in Adult Offspring. | Q50530256 | ||
| Obesity during pregnancy disrupts placental morphology, cell proliferation, and inflammation in a sex-specific manner across gestation in the mouse. | Q50662556 | ||
| Changes in booking body mass index over a decade: retrospective analysis from a Glasgow Maternity Hospital. | Q52039249 | ||
| Maternal supply of BDNF to mouse fetal brain through the placenta. | Q54501219 | ||
| Activation of AMPK in Human Placental Explants Impairs Mitochondrial Function and Cellular Metabolism. | Q54978526 | ||
| Combined maternal and postnatal high-fat diet leads to metabolic syndrome and is effectively reversed by resveratrol: a multiple-organ study. | Q55410092 | ||
| INFANT MORTALITY, CHILDHOOD NUTRITION, AND ISCHAEMIC HEART DISEASE IN ENGLAND AND WALES | Q56619923 | ||
| Developmental Programming of the Metabolic Syndrome: Can We Reprogram with Resveratrol? | Q57844786 | ||
| Resveratrol, Metabolic Syndrome, and Gut Microbiota | Q58614694 | ||
| Maternal obesity influences expression and DNA methylation of the adiponectin and leptin systems in human third-trimester placenta | Q61797828 | ||
| Maternal resveratrol treatment during pregnancy improves adverse fetal outcomes in a rat model of severe hypoxia | Q83414668 | ||
| Pregestational overweight and obesity are associated with differences in gut microbiota composition and systemic inflammation in the third trimester | Q90036829 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P433 | issue | 5 | |
| P921 | main subject | maternal obesity | Q108582152 |
| resveratrol | Q407329 | ||
| prenatal exposure delayed effects | Q54911376 | ||
| P577 | publication date | 2020-03-02 | |
| P1433 | published in | International Journal of Environmental Research and Public Health | Q6051382 |
| P1476 | title | Maternal Obesity Programs Offspring Development and Resveratrol Potentially Reprograms the Effects of Maternal Obesity | |
| P478 | volume | 17 |
Search more.